Biotech

All Articles

ArsenalBio raises $325M, pivots off of past lead possession

.Arsenal Biosciences is carrying on up. The tissue treatment provider has added $325 million in ammu...

Lilly- backed weight-loss biotech data IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' cannabis usage medicine fails period 2b, driving Indivior to reassess $100M option

.Aelis Farma's hopes of securing a fast, favorable decision on a $one hundred million alternative se...

ProKidney halts period 3 test not needed to have for tissue therapy approval

.ProKidney has actually ceased among a pair of period 3 trials for its own tissue treatment for kidn...

Vaxcyte surges on 'magnificent' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals named "magnificent" stage 1/2 information for its own 31-vale...

Recursion's brain illness test reveals insufficient evidence of efficiency

.Recursion has actually stumbled by means of an early test of its tech-enabled strategy to medicine ...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Call it a situation of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winni...

Praxis epilepsy drug lessens confiscations in phase 2 hearing

.Practice Preciseness Medicines has actually scored another midphase win in epilepsy this year, alon...

Three execs resign as Dyne posts blended data for DMD candidate

.After leaving a professional hold a number of years back, Dyne Therapeutics has actually exposed br...

Arrowhead fires off phase 3 records in unusual metabolic illness ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in advance of a potential face-off along with...